These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5156951)

  • 21. [Sympathomimetic amines of current use. Cardiocirculatory effect in normal dogs. Observations].
    Aquino AB
    Hospital (Rio J); 1968 Nov; 74(5):1543-52. PubMed ID: 5305332
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiotonic effects of glucagon].
    Robert M; Humair L
    Schweiz Med Wochenschr; 1970 Aug; 100(31):1345-52. PubMed ID: 5513359
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiogenic shock following acute myocardial infarction and the role of ethyl adrianol in its treatment.
    Lim CH; Toh CC
    Singapore Med J; 1972 Aug; 13(4):172-7. PubMed ID: 5084232
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on 1-(6'-chloro-3'-methylphenoxy)-3-tert.-butylaminopropane-2-olhydrochloride (KL 255). 3. Effect of intrevenous administration on the normal and fully digitalized organism].
    Waterloh E; Rittel HF; Leide E
    Arzneimittelforschung; 1969 Oct; 19(10):1704-10. PubMed ID: 5395372
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and endotoxin shock in rats and rabbits.
    Ohnishi H; Yamaguchi K; Sato M; Uemura A; Funato H; Dabasaki T
    Circ Shock; 1984; 13(3):261-70. PubMed ID: 6467523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dopamine in the treatment of coronary shock].
    Zimin IuV; Kuznetsova GV; Evdokimov VV
    Kardiologiia; 1979 May; 19(5):34-9. PubMed ID: 459209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit].
    Amtorp O; Christiansen I; Wennevold A
    Ugeskr Laeger; 1971 May; 133(18):867-70. PubMed ID: 5577747
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contribution to the treatment of hypotension].
    Mann D; Seefeldt H
    Z Arztl Fortbild (Jena); 1969 Jun; 63(11):596-600. PubMed ID: 5806766
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
    Mehta RH; Califf RM; Yang Q; Pieper KS; White HD; Ohman EM; Harrington RA; Granger CB
    Am J Cardiol; 2007 Mar; 99(6):793-6. PubMed ID: 17350367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J; Lopes AS; Lopes JS; Vergara M; Benchimol AB
    Arq Bras Cardiol; 1972 Jun; 25(3):231-9. PubMed ID: 5079398
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 33. [1st clinical studies in therapy of shock with ornithine-8-vasopressin (POR-8)].
    Alsweiler W; Opderbecke HW
    Z Prakt Anasth; 1970 Apr; 5(2):91-104. PubMed ID: 4256223
    [No Abstract]   [Full Text] [Related]  

  • 34. [Trieffortil in peridural and subarachnoid spinal anesthesia].
    Rossano C; Testasecca D; Giugliano F
    Minerva Anestesiol; 1971 Oct; 37(10):356-60. PubMed ID: 5158412
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological basis for the use of adrenergic agonists and antagonists in cardiogenic shock and hypotension.
    MacCannell KL; Moran NC
    Prog Cardiovasc Dis; 1967 Jul; 10(1):55-63. PubMed ID: 5343158
    [No Abstract]   [Full Text] [Related]  

  • 36. [Central venous pressure in control of cardiogenic shock].
    Gavrilescu S; Cotoi S; Riviş I
    Med Interna (Bucur); 1968 Nov; 20(11):1361-8. PubMed ID: 5731992
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical evaluation of an oral analgesic, Z.424, in patients with chronic pain.
    Martinetti L; Lodola E; Monafo V; Ferrari V
    J Clin Pharmacol J New Drugs; 1970; 10(6):390-9. PubMed ID: 4920491
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopamine and cardiogenic shock].
    Guerricchio G
    Clin Ter; 1969 May; 49(4):383-8. PubMed ID: 5795024
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of corticosteroids on the circulation in shock: experimental and clinical results.
    Motsay GJ; Alho A; Jaeger T; Dietzman RH; Lillehei RC
    Fed Proc; 1970; 29(6):1861-73. PubMed ID: 5482719
    [No Abstract]   [Full Text] [Related]  

  • 40. Using sympathomimetic drugs to manage hypotension. 1: The cardiovascular system.
    Higginson R; Jones B
    Nurs Times; 2009 Apr 14-20; 105(14):22-3. PubMed ID: 19449604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.